334 related articles for article (PubMed ID: 2981379)
1. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Kirby LG; Rowan GA; Smith RL; Lucki I
Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
Stephens DN; Shearman GT; Kehr W
Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
[TBL] [Abstract][Full Text] [Related]
5. DMCM: a potent convulsive benzodiazepine receptor ligand.
Petersen EN
Eur J Pharmacol; 1983 Oct; 94(1-2):117-24. PubMed ID: 6317396
[TBL] [Abstract][Full Text] [Related]
6. Ro 15-4513, a partial inverse agonist for benzodiazepine recognition sites, has proconflict and proconvulsant effects in the rat.
Corda MG; Giorgi O; Longoni B; Biggio G
Eur J Pharmacol; 1989 Jan; 159(3):233-9. PubMed ID: 2537736
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine receptor mediated discriminative cues: effects of GABA-ergic drugs and inverse agonists.
Nielsen EB; Valentine JD; Holohean AM; Appel JB
Life Sci; 1983 Nov; 33(22):2213-20. PubMed ID: 6316057
[TBL] [Abstract][Full Text] [Related]
8. Inverse agonist properties of the FG 7142 discriminative stimulus.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons.
Mehta AK; Ticku MK
J Pharmacol Exp Ther; 1989 May; 249(2):418-23. PubMed ID: 2542529
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol.
Buck KJ; Harris RA
J Pharmacol Exp Ther; 1990 May; 253(2):713-9. PubMed ID: 2160008
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]DMCM, a convulsive benzodiazepine ligand, to rat brain membranes: preliminary studies.
Braestrup C; Nielsen M; Honoré T
J Neurochem; 1983 Aug; 41(2):454-65. PubMed ID: 6308161
[TBL] [Abstract][Full Text] [Related]
12. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
Im HK; Im WB; Carter DB; McKinley DD
Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the beta-carboline ZK 93 426 as a benzodiazepine receptor antagonist.
Jensen LH; Petersen EN; Braestrup C; Honoré T; Kehr W; Stephens DN; Schneider H; Seidelmann D; Schmiechen R
Psychopharmacology (Berl); 1984; 83(3):249-56. PubMed ID: 6089247
[TBL] [Abstract][Full Text] [Related]
14. Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy.
Stephens DN; Schneider HH; Kehr W; Jensen LH; Petersen E; Honore T
Brain Res Bull; 1987 Sep; 19(3):309-18. PubMed ID: 2824003
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. I. Acute effects of ethanol.
Buck KJ; Harris RA
J Pharmacol Exp Ther; 1990 May; 253(2):706-12. PubMed ID: 2160007
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of ethyl-beta-carboline-3-carboxylate at two training doses in rats.
Rowlett JK; Wilcox KM; Woolverton WL
Psychopharmacology (Berl); 1999 Aug; 145(3):324-32. PubMed ID: 10494582
[TBL] [Abstract][Full Text] [Related]
18. Beta-carboline interactions at the BZ-GABA receptor chloride-ionophore complex in the rat cerebral cortex.
Malatynska E; Knapp R; Ikeda M; Yamamura HI
Brain Res Bull; 1989 May; 22(5):845-8. PubMed ID: 2548678
[TBL] [Abstract][Full Text] [Related]
19. Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM.
Nutt DJ; Little HJ; Taylor SC; Minchin MC
Eur J Pharmacol; 1984 Aug; 103(3-4):359-62. PubMed ID: 6092108
[TBL] [Abstract][Full Text] [Related]
20. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
